在突变的RAS上加倍可以MEK或打破白血病
Zuzana Tothova1, Benjamin L Ebert1
1Brigham and Women's Hospital, Division of Hematology, Boston, MA 02115, USA; Dana Farber Cancer Institute, Department of Medical Oncology, Boston, MA 02115, USA; Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA.
Cell
|February 25, 2017
概括
研究人员研究了KRAS突变如何影响急性髓性白血病中癌细胞生长和对MEK抑制剂的反应. 他们发现突变和正常KRAS的平衡可以预测治疗的有效性, 这表明了新的生物标志物.
科学领域:
- 癌症学
- 分子生物学
- 癌症遗传学
背景情况:
- RAS途径是癌症治疗的关键目标,但有效的向仍然是一个挑战.
- KRAS突变是各种癌症的常见驱动因素,包括急性髓性白血病 (AML).
- 了解突变型和野生型KRAS之间的相互作用对于开发向疗法至关重要.
研究的目的:
- 调查突变型和野生型KRAS的相对表达如何影响AML中的克隆适应性.
- 确定KRAS表达水平对MEK抑制剂敏感性的影响.
- 评估KRAS表达作为AML中MEK抑制剂治疗的预测生物标志物的潜力.
主要方法:
- 使用一个KrasG12D突变AML小鼠模型.
- 量化了突变型和野生型KRAS基因的相对表达.
- 在不同的KRAS表达场景下评估了克隆健康和瘤生长.
- 根据KRAS突变状态评估了对MEK抑制剂治疗的反应.
主要成果:
- 在AML模型中,突变KRAS与野生型KRAS的比例显著调节了克隆适应性.
- 不同的KRAS表达水平与对MEK抑制剂的不同敏感性相关.
- 在治疗反应方面确定了特定的KRAS表达特征.
结论:
- 突变型和野生型KRAS的相对表达是克隆适应性和KrasG12DAML中MEK抑制剂敏感性的关键决定因素.
- 作为指导AML患者使用MEK抑制剂治疗的预测生物标志物,KRAS表达水平具有前景.
- 需要进一步的临床验证,以确定KRAS表达是瘤学中的可靠生物标志物.
相关概念视频
02:38The Ras Gene
7.4K
The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...
Ras is a...
7.4K
01:24Small GTPases - Ras and Rho
5.6K
Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:
Three regulatory proteins control their activity:
5.6K
01:07MAPK Signaling Cascades
8.9K
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
8.9K
02:23Abnormal Proliferation
5.3K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.3K
01:03Rous Sarcoma Virus (RSV) and Cancer
6.5K
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
6.5K
01:16In-vitro Mutagenesis
17.4K
To learn more about the function of a gene, researchers can observe what happens when the gene is inactivated or “knocked out,” by creating genetically engineered knockout animals. Knockout mice have been particularly useful as models for human diseases such as cancer, Parkinson’s disease, and diabetes.
17.4K